Search research articles
Contact Us
Filters
Showing results (71-80 of 83) with videos related to
Page
of 9
Sort By:
Molecular Pharmacology
|
March 13, 2010
Genetic and functional analysis of human P2X5 reveals a distinct pattern of exon 10 polymorphism with predominant expression of the nonfunctional receptor isoform
Smita Kotnis, Brendan Bingham, Dmitry V Vasilyev, et al.
Nature Communications
|
March 23, 2023
YBX1 integration of oncogenic PI3K/mTOR signalling regulates the fitness of malignant epithelial cells
Yuchen Bai, Carolin Gotz, Ginevra Chincarini, et al.
European Urology
|
August 14, 2016
Targeted Exome Sequencing of the Cancer Genome in Patients with Very High-risk Bladder Cancer
Thomas Longo, Kathleen F McGinley, Jennifer A Freedman, et al.
Journal of Nanobiotechnology
|
May 16, 2025
Dual-source powered sea urchin-like nanomotors for intravesical photothermal therapy of bladder cancer
Yixuan Mou, Zhenghong Liu, Wentao Xu, et al.
Clinical & Translational Immunology
|
August 25, 2025
Optimised modular anti-FLAG CAR T cells for solid tumor therapy
Xiaomeng Zhang, Rachel Xu, Dmitry Zorin, et al.
Journal of Nanobiotechnology
|
March 17, 2026
A 'two-in-one' tumor-specific-hydrogel-assisted strategy for intravesical chemotherapy and protection of normal tissues
Xiaowen Qin, Bin Zheng, Dingyi Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 3, 2021
A Histone Deacetylase Inhibitor, Panobinostat, Enhances Chimeric Antigen Receptor T-cell Antitumor Effect Against Pancreatic Cancer
Aesha I Ali, Minyu Wang, Bianca von Scheidt, et al.
Nature Communications
|
May 17, 2018
Comprehensive epigenetic landscape of rheumatoid arthritis fibroblast-like synoviocytes
Rizi Ai, Teresina Laragione, Deepa Hammaker, et al.
Molecular Cancer Therapeutics
|
September 26, 2014
A687V EZH2 is a driver of histone H3 lysine 27 (H3K27) hypertrimethylation
Heidi M Ott, Alan P Graves, Melissa B Pappalardi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 23, 2015
Combined BRAF and MEK Inhibition With Dabrafenib and Trametinib in BRAF V600-Mutant Colorectal Cancer
Ryan B Corcoran, Chloe E Atreya, Gerald S Falchook, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 83) with videos related to
Sort By:
Page
of 9
Molecular Pharmacology
|
March 13, 2010
Genetic and functional analysis of human P2X5 reveals a distinct pattern of exon 10 polymorphism with predominant expression of the nonfunctional receptor isoform
Smita Kotnis, Brendan Bingham, Dmitry V Vasilyev, et al.
Nature Communications
|
March 23, 2023
YBX1 integration of oncogenic PI3K/mTOR signalling regulates the fitness of malignant epithelial cells
Yuchen Bai, Carolin Gotz, Ginevra Chincarini, et al.
European Urology
|
August 14, 2016
Targeted Exome Sequencing of the Cancer Genome in Patients with Very High-risk Bladder Cancer
Thomas Longo, Kathleen F McGinley, Jennifer A Freedman, et al.
Journal of Nanobiotechnology
|
May 16, 2025
Dual-source powered sea urchin-like nanomotors for intravesical photothermal therapy of bladder cancer
Yixuan Mou, Zhenghong Liu, Wentao Xu, et al.
Clinical & Translational Immunology
|
August 25, 2025
Optimised modular anti-FLAG CAR T cells for solid tumor therapy
Xiaomeng Zhang, Rachel Xu, Dmitry Zorin, et al.
Journal of Nanobiotechnology
|
March 17, 2026
A 'two-in-one' tumor-specific-hydrogel-assisted strategy for intravesical chemotherapy and protection of normal tissues
Xiaowen Qin, Bin Zheng, Dingyi Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 3, 2021
A Histone Deacetylase Inhibitor, Panobinostat, Enhances Chimeric Antigen Receptor T-cell Antitumor Effect Against Pancreatic Cancer
Aesha I Ali, Minyu Wang, Bianca von Scheidt, et al.
Nature Communications
|
May 17, 2018
Comprehensive epigenetic landscape of rheumatoid arthritis fibroblast-like synoviocytes
Rizi Ai, Teresina Laragione, Deepa Hammaker, et al.
Molecular Cancer Therapeutics
|
September 26, 2014
A687V EZH2 is a driver of histone H3 lysine 27 (H3K27) hypertrimethylation
Heidi M Ott, Alan P Graves, Melissa B Pappalardi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 23, 2015
Combined BRAF and MEK Inhibition With Dabrafenib and Trametinib in BRAF V600-Mutant Colorectal Cancer
Ryan B Corcoran, Chloe E Atreya, Gerald S Falchook, et al.
Page
of 9